{
  "report_rows": [
    {
      "kpi": "2Q26 recurring EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.96 vs. cons $0.94",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2Q26 operating revenue",
      "prediction": "BEAT",
      "answer": "pred ~$3.05B vs. cons $2.98B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2Q26 Parent and Other loss",
      "prediction": "MISS",
      "answer": "pred ~-$82M vs. cons -$80M",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "2026 recurring EPS guidance midpoint",
      "prediction": "UNCHANGED",
      "answer": "guide ~$4.645 vs. cons $4.65 (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Long-term recurring EPS growth midpoint",
      "prediction": "UNCHANGED",
      "answer": "guide ~6.0% vs. cons 6.0% (2026-2030 CAGR)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Planned common-equity issuance midpoint",
      "prediction": "UNCHANGED",
      "answer": "guide ~$0.95B vs. cons $0.95B (2026-2030)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Storm-securitization proceeds",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.39B vs. cons $1.40B (next 12-18 months)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Prospective New England transmission base ROE",
      "prediction": "UNCHANGED",
      "answer": "guide ~11.39% vs. cons 11.39% (expected by December 2026, subject to refund)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 0.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.6,
  "day5_path": "STABILIZE",
  "day5_rationale": "day-5 residual ~0.6% vs. day-1 residual 0.8%; a modest EPS beat and unchanged FY2026 guidance support the shares, but unchanged out-period growth, persistent parent-company drag and unresolved FERC/rate-case risks limit estimate revisions and broader follow-through.",
  "day5_confidence": "MEDIUM"
}